Sernova Corp.

Sernova Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
167.97 M
Public Float
-
Sernova Corp.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.02
Market Cap
CAD37.97 M
Shares Outstanding
172.24 M
Public Float
165.73 M

Profile

Address
700 Collip Circle
London Ontario N6G 4X8
Canada
Employees -
Website http://www.sernova.com
Updated 07/08/2019
Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. It also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes.

Financials

View All

Philip M. Toleikis
President, Chief Executive Officer & Director
Frank A. Holler
Chairman